| 28th Annual JPMorgan Healthcare Conference--Forest Laboratories and Icagen. | |
| | |
MedLine Citation:
|
PMID: 20191426 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The JPMorgan Healthcare conference, held in San Francisco, included presentations by various pharmaceutical companies summarizing their achievements in 2009 and expectations for 2010. This conference report highlights presentations from Forest Laboratories Inc and Icagen Inc. Investigational drugs from Forest Laboratories, including roflumilast (in collaboration with Nycomed Inc/Mitsubishi Tanabe Pharma Corp), ceftaroline fosamil (with AstraZeneca plc), linaclotide (with Ironwood Pharmaceuticals Inc/Astellas Pharma Inc/Almirall Prodesfarma SA), cariprazine (with Gedeon Richter Ltd/Mitsubishi Tanabe Pharma Corp), aclidinium bromide (with Almirall), dutogliptin (with Phenomix Corp/Chiesi Farmaceutici SpA) and levomilnacipran (with Pierre Fabre SA), and from Icagen, including ICA-105665, are discussed. |
| | |
Authors:
|
Sophie Gale; Gary Croasdell |
Related Documents
:
|
12602216 - The carl o. boucher prosthodontic conference spans four decades. 20666716 - Meetings and courses calendar. 20665976 - The quality of reporting and publication status of vaccines trials presented at veterin... 20802466 - International society of urological pathology (isup) consensus conference on handling a... 21570746 - The first catalan neurological societies and their protagonists. 3262446 - Consultation with directors of who collaborating centres on influenza: memorandum from ... |
Publication Detail:
|
Type: Congresses |
Journal Detail:
|
Title: IDrugs : the investigational drugs journal Volume: 13 ISSN: 2040-3410 ISO Abbreviation: IDrugs Publication Date: 2010 Mar |
Date Detail:
|
Created Date: 2010-03-01 Completed Date: 2010-05-13 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 100883655 Medline TA: IDrugs Country: England |
Other Details:
|
Languages: eng Pagination: 145-8 Citation Subset: IM |
Affiliation:
|
Thomson Reuters, 77 Hatton Garden, London, EC1N 8JS, UK. sophie.gale@thomsonreuters.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Anti-Bacterial Agents / therapeutic use Antipsychotic Agents / therapeutic use Drug Evaluation, Preclinical Drug Industry* Drugs, Investigational / therapeutic use* Gastrointestinal Agents / therapeutic use Humans Hypoglycemic Agents / therapeutic use Potassium Channel Blockers / therapeutic use Respiratory System Agents / therapeutic use Treatment Outcome |
| Chemical | |
Reg. No./Substance:
|
0/Anti-Bacterial Agents; 0/Antipsychotic Agents; 0/Drugs, Investigational; 0/Gastrointestinal Agents; 0/Hypoglycemic Agents; 0/Potassium Channel Blockers; 0/Respiratory System Agents |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: 28th Annual JPMorgan Healthcare Conference - Affymax and Infinity Pharmaceuticals.
Next Document: High-Content Analysis - CHI's Seventh Annual Conference - Developments in HCA and Pathway Analysis.